Mosunetuzumab
Mosunetuzumab | |
---|---|
Term | Mosunetuzumab |
Short definition | Mosunetuzumab - (moh-SUN-eh-TOO-zoo-mab) drug used to treat adults with follicular lymphoma that has come back or has not improved after treatment with at least two other systemic therapies. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Mosunetuzumab - (moh-SUN-eh-TOO-zoo-mab) drug used to treat adults with follicular lymphoma that has come back or has not improved after treatment with at least two other systemic therapies. It is also being studied in the treatment of other types of cancer. Mosunetuzumab attaches to a protein called CD3, which is found on T cells (a type of white blood cell). It also attaches to a protein called CD20, which is found on B cells (another type of white blood cell) and some lymphoma cells. This can help the immune system kill cancer cells. Mosunetuzumab is a type of bispecific monoclonal antibody. Also called Lunsumio
External links
- Medical encyclopedia article on Mosunetuzumab
- Wikipedia's article - Mosunetuzumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski